These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 2420011)

  • 1. Immunobiology of human gliomas.
    Bullard DE; Gillespie GY; Mahaley MS; Bigner DD
    Semin Oncol; 1986 Mar; 13(1):94-109. PubMed ID: 2420011
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas.
    Lee Y; Bigner DD
    Neurol Clin; 1985 Nov; 3(4):901-17. PubMed ID: 2417097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological aspects of intrinsic glial tumors.
    Apuzzo ML; Mitchell MS
    J Neurosurg; 1981 Jul; 55(1):1-18. PubMed ID: 7017079
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value of immunologic studies in malignant tumors of the human brain].
    Romodanov AP; Lisianyĭ NI; Prikhodchenko IA
    Zh Vopr Neirokhir Im N N Burdenko; 1983; (3):56-9. PubMed ID: 6310917
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunobiologic aspects of the brain and human gliomas. A review.
    Wikstrand CJ; Bigner DD
    Am J Pathol; 1980 Feb; 98(2):517-68. PubMed ID: 6986786
    [No Abstract]   [Full Text] [Related]  

  • 6. New therapeutic approaches to treatment of malignant gliomas: chemotherapy and immunotherapy.
    Mahaley MS; Gillespie GY
    Clin Neurosurg; 1983; 31():456-69. PubMed ID: 6680086
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Immunological investigations on human brain tumor patients.
    Mahaley MS
    Proc Natl Cancer Conf; 1972; 7():811-5. PubMed ID: 4358071
    [No Abstract]   [Full Text] [Related]  

  • 8. Interleukin-2 activated cytotoxic lymphocytes and their application in the intraoperative immunotherapy of local tumors.
    Grimm EA
    Prog Clin Biol Res; 1987; 244():185-95. PubMed ID: 3498948
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunobiology of brain tumors.
    Frank E; de Tribolet N
    Neurosurg Rev; 1986; 9(1-2):31-7. PubMed ID: 3090477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of brain tumors--is there a future?
    Mahaley MS
    Clin Neurosurg; 1978; 25():382-7. PubMed ID: 710003
    [No Abstract]   [Full Text] [Related]  

  • 11. Gliomas: new ways of treatment?
    van Acker RE
    Clin Neurol Neurosurg; 1977; 80(2):112-5. PubMed ID: 209922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological aspects of gliomas.
    Ridley A
    Proc R Soc Med; 1977 Dec; 70(12):867-9. PubMed ID: 601065
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunotherapy of brain tumors].
    Takakura K; Watanabe T
    No Shinkei Geka; 1982 Dec; 10(12):1245-54. PubMed ID: 6188989
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunology of human brain tumors.
    Coakham HB
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):145-9. PubMed ID: 6363093
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunologic approaches to the management of ovarian carcinoma.
    Bast RC; Knapp RC
    Semin Oncol; 1984 Sep; 11(3):264-74. PubMed ID: 6207593
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunotherapy of malignant gliomas.
    Jaeckle KA
    Semin Oncol; 1994 Apr; 21(2):249-59. PubMed ID: 8153668
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunology of gliomas.
    de Tribolet N
    Childs Nerv Syst; 1989 Apr; 5(2):60-5. PubMed ID: 2660987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cellular immunotherapy for malignant glioma].
    Okamoto Y; Yamashita J
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():557-62. PubMed ID: 16201581
    [No Abstract]   [Full Text] [Related]  

  • 19. BCG in tumor immunotherapy.
    Baldwin RW; Pimm MV
    Adv Cancer Res; 1978; 28():91-147. PubMed ID: 360797
    [No Abstract]   [Full Text] [Related]  

  • 20. A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.
    Bullard DE; Thomas DG; Darling JL; Wikstrand CJ; Diengdoh JV; Barnard RO; Bodmer JG; Bigner DD
    Br J Cancer; 1985 Feb; 51(2):283-9. PubMed ID: 3966985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.